Skip Navigation
 
 
 
 

Specialty, Disease or Condition


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z More Search Options
More Search Options
Locations     Health Topic  

Languages

Search all languages or select any specific language(s) from our A-Z listing below.
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z    

Gender

 
Print This Page
Share this page: More
 

Michelle A Petri, MD

Title(s):
Professor of Medicine
Director, Hopkins Lupus Center

Appointment Phone:
410-955-9114 x6

Primary Location:
Johns Hopkins Outpatient Center

Expertise:
General Internal Medicine, Systemic Lupus Erythematosus

Education and Experience

Training
  • Harvard Medical School (Boston MA)/ (1980)
Residencies
  • Massachusetts General Hospital (Boston MA)/ (1983)
Fellowships
  • University of California San Francisco (San Francisco CA)/ (1986)
Certifications
  • Rheumatology, American Board of Internal Medicine (1986)
  • Allergy & Immunology, American Board of Allergy & Immunology (1985)
  • Internal Medicine, American Board of Internal Medicine (1983)

Locations

Johns Hopkins Outpatient Center
601 N. Caroline Street
above Room above
Baltimore, MD 21287
Phone: 410-955-9114
Appointment Phone: 410-955-9114 x6
Fax: 410-614-0498
Location Map
Department / Division
  • Medicine - Rheumatology

Centers/Institutes

Centers / Institutes
  • Hopkins Lupus Center

Bio

Biography
Michelle Petri, M.D.
Professor of Medicine, Johns Hopkins University

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center.

Appointments:
7/85 - 6/86: Instructor, Medicine, Division of Rheumatology, Univ. of California, San Francisco, CA
7/86-1/92: Assistant Professor, Medicine, Johns Hopkins Univ. School of Medicine, Baltimore, MD
1/92-5/01: Associate Professor, Medicine, Johns Hopkins Univ. School of Medicine, Baltimore, MD
5/01-current: Professor, Medicine, Johns Hopkins Univ. School of Medicine, Baltimore, MD

Post-graduate Training:
1980-1983 Residency in Internal Medicine, Massachusetts General Hospital, Boston, MA
1983-1985 Fellowship in Allergy and Immunology, Univ. of California, San Francisco, CA
1983-1986 Fellowship in Rheumatology, University of California, San Francisco, CA

Degrees: Board Certified in Internal Medicine (1983, Allergy and Immunology (1985), Rheumatology (1986)

Honors: Merit Scholar, Phi Beta Kappa
1988 - 1991 Clinical Associate Physician Award (NIH)
1991 - 1993 Hopkins Clinician Scientist
1993 Dubois Award, American College of Rheumatology
Physician Title
Director, Hopkins Lupus Center
Awards and Honors
NIH Clinical Associate Physician Award, Dec. 1988 to 1991
Hopkins Clinician Scientist, 1991-1992
Edmund L. Dubois Award, American College of Rheumatology, Southeast Region, 1993
Listed in Americas Top Doctors, Castle Connolly Medical Ltd., 2003-2008
Listed in Guide to Americas Top Physicians, Consumers Research Council of America, 2004-2005 edition.
Listed in Best Doctors in America 2005-2008.
Listed in Whos Who in America 2009 edition.
Expertise
  • General Internal Medicine
  • Systemic Lupus Erythematosus

Research

Research and Publications
SELECTED PEER-REVIEWED PUBLICATIONS (IN CHRONOLOGICAL ORDER)

1. Petri M, Jones RJ, Brodsky RA. High dose immunoblative cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 166-173. PMID: 12528116.
2. Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum, 2004; 50(9): 2858-2868. PMID: 15452837.
3. Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus, 2004; 13(9): 688-689. PMID: 15485104.
4. Petri MA. Calssification criteria for antiphospholipid syndrome: the case for cardiac valvular disease. J Rheumatol, 2004; 31(12): 2329-2330. PMID: 15570630.
5. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP; OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med , 2005; 353(24): 2550-2558. PMID: 16354891.
6. Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, Sampedro M, Narayana S, Fox PT, Franklin C, Padilla PA, Brey RL. Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus. J Rheumatol, 2008; 35(12): 2348-2354. PMID: 18793003.
7. Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, Ryel J, Recta V, Zhong J, Freimuth W. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum, 2008; 58(8): 2453-2459. PMID: 18668552.
8. Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, Holliday SL, Padilla PA, Brey RL. Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol, 2008; 35(9): 1776-1781. PMID: 18634154.
9. Petri M, Kasitanon N, Lee SS, Link K, Magder L, Bae SC, Hanly JG, Isenberg DA, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcn GS, Adu D, Avila-Casado C, Bernatsky SR, Bruce IN, Clarke AE, Contreras G, Fine DM, Gladman DD, Gordon C, Kalunian KC, Madaio MP, Rovin BH, Sanchez-Guerrero J, Steinsson K, Aranow C, Balow JE, Buyon JP, Ginzler EM, Khamashta MA, Urowitz MB, Dooley MA, Merrill JT, Ramsey-Goldman R, Font J, Tumlin J, Stoll T, Zoma A; Systemic Lupus International Collaborating Clinics. Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum, 2008; 58(6): 1784-1788. PMID: 18512819.
10. Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, Hanly JG, Nived O, Sturfelt G, van Vollenhoven R, Wallace DJ, Alarcn GS, Adu D, Avila-Casado C, Bernatsky SR, Bruce IN, Clarke AE, Contreras G, Fine DM, Gladman DD, Gordon C, Kalunian KC, Madaio MP, Rovin BH, Sanchez-Guerrero J, Steinsson K, Aranow C, Balow JE, Buyon JP, Ginzler EM, Khamashta MA, Urowitz MB, Dooley MA, Merrill JT, Ramsey-Goldman R, Font J, Tumlin J, Stoll T, Zoma A; Systemic Lupus International Collaborating Clinics. Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum, 2008; 58(6): 1789-1995. PMID: 18512814.
11. Petri M, Singh S, Tesfasyone H, Malik A. Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study. J Rheumatol, 2009; 36(11): 2476-2480. PMID: 19833757.
12. Petri M, Brodsky RA, Jones RJ, Gladstone D, Fillius M, Magder LS. High-Dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial. Arthritis Rheum, 2010; 62(5): 1487-1493. PMID: 20131296 [PMCID: PMC2911961].
13. Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, Sampedro M, Padilla PA, Brey RL. Depression and cognitive impairment in newly diagnosed Systemic Lupus Erythematosus (SLE). J Rheumatol, 2010; 37(10): 2032-2038. PMID: 20634244.
14. Petri M, Naqibuddin M, Sampedro M, Omdal R, Carson KA. Memantine in systemic lupus erythematosus: A randomized, double-blind placebo-controlled trial. Semin Arthritis Rheum, 2011; 41:194-202. PMID: 21458845 [PMCID: PMC3153605].
15. Petri M, Orbai A-M, Alarcn GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz MB, Gladman DD, Kalunian K, Costner M, Werth V, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta M, Jacobsen S, Buyon JP, Maddison P, Dooley MA, Van Vollenhoven R, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim S, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks Jr. AG , Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin Jr. G, Magder LS. Derivation and validation of Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus. Arthritis Rheum, 2012; 64(8):2677-2686. PMID: 22553077 [PMCID: PMC3409311].
Research Interests
  • Lupus; Antiphospholipid Syndrome

More Info

Languages
  • English
  • French
Memberships
American College of Rheumatology
Lupus Foundation of America
Clinical Trials
  • Lupus
Additional Resources
 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer